(Q57594200)

1

0 references

Spyros Deraos

2

0 references

Theodore V Tselios

3

0 references

Geoffrey Pietersz

4

0 references

John Matsoukas

Induction of experimental allergic encephalomyelitis by myelin proteolipid-protein-specific T cell clones and synthetic peptides

5

0 references

publication date

June 2014

0 references

published in

Immunotherapy

0 references

volume

6

0 references

issue

6

0 references

page(s)

709-724

0 references

cites work

1 reference

T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination.

21 January 2018

1 reference

Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system

21 January 2018

1 reference

In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis

21 January 2018

1 reference

A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens

21 January 2018

1 reference

IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

21 January 2018

1 reference

Design of novel cyclic altered peptide ligands of myelin basic protein MBP83-99 that modulate immune responses in SJL/J mice

21 January 2018

1 reference

Design and Synthesis of a Cyclic Double Mutant Peptide (cyclo(87−99)[A91,A96]MBP87−99) Induces Altered Responses in Mice after Conjugation to Mannan: Implications in the Immunotherapy of Multiple Sclerosis

21 January 2018

1 reference

A double mutation of MBP83–99 peptide induces IL-4 responses and antagonizes IFN-γ responses

21 January 2018

1 reference

Mannosylation of mutated MBP83-99 peptides diverts immune responses from Th1 to Th2.

21 January 2018

1 reference

Altered peptide ligands of myelin basic protein ( MBP87-99 ) conjugated to reduced mannan modulate immune responses in mice

21 January 2018

1 reference

Oxidative/reductive conjugation of mannan to antigen selects for T1 or T2 immune responses.

21 January 2018

1 reference

Cell-mediated immune responses to MUC1 fusion protein coupled to mannan

21 January 2018

1 reference

Round and round we go: cyclic peptides in disease

21 January 2018

1 reference

Design and synthesis of a novel potent myelin basic protein epitope 87-99 cyclic analogue: enhanced stability and biological properties of mimics render them a potentially new class of immunomodulators.

21 January 2018

1 reference

Antagonistic Effects of Human Cyclic MBP87-99Altered Peptide Ligands in Experimental Allergic Encephalomyelitis and Human T-Cell Proliferation

21 January 2018

1 reference

Treatment of experimental allergic encephalomyelitis (EAE) by a rationally designed cyclic analogue of myelin basic protein (MBP) epitope 72-85.

21 January 2018

1 reference

Treatment of experimental allergic encephalomyelitis (EAE) induced by guinea pig myelin basic protein epitope 72-85 with a human MBP(87-99) analogue and effects of cyclic peptides

21 January 2018

1 reference

Design and synthesis of a potent cyclic analogue of the myelin basic protein epitope MBP72-85: importance of the Ala81 carboxyl group and of a cyclic conformation for induction of experimental allergic encephalomyelitis

21 January 2018

1 reference

Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses.

21 January 2018

1 reference

Synthesis and study of the electrophoretic behavior of mannan conjugates with cyclic peptide analogue of myelin basic protein using lysine-glycine linker

21 January 2018

1 reference

CHARMM: the biomolecular simulation program

21 January 2018

1 reference

A combined NMR and molecular dynamics simulation study to determine the conformational properties of agonists and antagonists against experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

Molecular dynamics at the receptor level of immunodominant myelin basic protein epitope 87–99 implicated in multiple sclerosis and its antagonists altered peptide ligands: Triggering of immune response

21 January 2018

1 reference

A putative bioactive conformation for the altered peptide ligand of myelin basic protein and inhibitor of experimental autoimmune encephalomyelitis [Arg91, Ala96] MBP87-99.

21 January 2018

1 reference

Comparison of Proposed Putative Active Conformations of Myelin Basic Protein Epitope 87−99 Linear Altered Peptide Ligands by Spectroscopic and Modelling Studies: The Role of Positions 91 and 96 in T-Cell Receptor Activation

21 January 2018

1 reference

Autopathogenic T helper cell type 1 (Th1) and protective Th2 clones differ in their recognition of the autoantigenic peptide of myelin proteolipid protein

21 January 2018

1 reference

Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells.

21 January 2018

1 reference